Pharmaceutical Preparations - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Pharmaceutical industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Pharmaceutical Preparations - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Pharmaceutical Preparations
Corporate Insider Buy Sell Ratio (Insider Count) - Pharmaceutical Preparations
Pharmaceutical Preparations - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-09-19 SAVA / Cassava Sciences, Inc. 4 Barry Richard By Trust P - Purchase I 2.29 46,908
2025-09-19 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-19 ROIV / Roivant Sciences Ltd. 4 Venker Eric M - Exercise D 3.85 1,000,000
2025-09-19 XOMA / XOMA Royalty Corporation 4 Hughes Owen M - Exercise D 35,567
2025-09-19 XOMA / XOMA Royalty Corporation 4 Sitko Bradley M - Exercise D 6,712
2025-09-19 XOMA / XOMA Royalty Corporation 4 Montano Maricel Perea M - Exercise D 3,033
2025-09-19 XOMA / XOMA Royalty Corporation 4 BURNS THOMAS M. M - Exercise D 11,846
2025-09-19 RCKT / Rocket Pharmaceuticals, Inc. 4 RTW INVESTMENTS, LP J - Other I 3.105 -1,000,000
2025-09-19 APLS / Apellis Pharmaceuticals, Inc. 4 Dunlop A. Sinclair Indirect Owner (Epidarex) J - Other I -3,837
2025-09-19 RCKT / Rocket Pharmaceuticals, Inc. 4 RTW INVESTMENTS, LP J - Other I 3.105 -41,000
2025-09-19 RCKT / Rocket Pharmaceuticals, Inc. 4 RTW INVESTMENTS, LP J - Other I 3.105 -59,000
2025-09-19 CORT / Corcept Therapeutics Incorporated 4 Guyer William G - Gift D -200
2025-09-19 PAHC / Phibro Animal Health Corporation 4 BENDHEIM JACK See C - Conversion I 30,000
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 408.1142 -1,200
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 407.4171 -2,105
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 404.3275 -1,100
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 405.4502 -2,973
2025-09-18 PGEN / Precigen, Inc. 4 KIRK RANDAL J by Kapital Joe S - Sale I 3.86 -1,403,360
2025-09-18 RARE / Ultragenyx Pharmaceutical Inc. 4 Huizenga Theodore Alan S - Sale D 29.17 -64
2025-09-18 PAHC / Phibro Animal Health Corporation 4 BENDHEIM JACK See S - Sale I 40.2637 -7,022
2025-09-18 BYSI / BeyondSpring Inc. 4 Decheng Capital China Life Sciences USD Fund III, L.P. By Decheng Capital China Life Sciences USD Fund III, L.P. S - Sale I 1.74 -5,307
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 402.50 -400
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A S - Sale D 406.3918 -3,222
2025-09-18 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 406.0356 -879
2025-09-18 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC S - Sale I 2.4673 -20,870
2025-09-18 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 403.2675 -2,000
2025-09-18 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 405.1961 -1,121
2025-09-18 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale D 1.4418 -366,111
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 764.519 -23,067
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 765.567 -26,647
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 767.065 -3,914
2025-09-18 LVTX / LAVA Therapeutics N.V. 4 Versant Venture Capital VI, L.P. S - Sale I 1.4418 -228,791
2025-09-18 OLMA / Olema Pharmaceuticals, Inc. 4 Harmon Cyrus S - Sale I 8.32 -3,086
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 763.292 -39,863
2025-09-18 LLY / Eli Lilly and Company 4 LILLY ENDOWMENT INC S - Sale D 766.451 -13,135
2025-09-18 OLMA / Olema Pharmaceuticals, Inc. 4 Harmon Cyrus S - Sale D 8.33 -10,000
2025-09-18 ROIV / Roivant Sciences Ltd. 4 Gline Matthew P - Purchase D 15.07 3,315
2025-09-18 SAVA / Cassava Sciences, Inc. 4 Barry Richard By Trust P - Purchase I 2.13 5,400
2025-09-18 SAVA / Cassava Sciences, Inc. 4 Barry Richard By Trust P - Purchase I 2.24 185,233
2025-09-18 CALC / CalciMedica, Inc. 4 Roberts Eric W By FMTC Custodian - Roth IRA FBO Eric W. Roberts P - Purchase I 3.07 2,500
2025-09-18 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A M - Exercise D 120.26 4,000
2025-09-18 UTHR / United Therapeutics Corporation 4 MAHON PAUL A M - Exercise D 135.42 11,000
2025-09-18 GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) 4 Coll Crespo Blas F - Taxes D 7.7433 -8,106
2025-09-18 GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock) 4 Hall Ashley F - Taxes D 7.7433 -6,021
2025-09-17 ALZN / Alzamend Neuro, Inc. 4 AULT MILTON C III By Ault Lending, LLC S - Sale I 2.4535 -2,121
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Halladay Benjamin S - Sale D 2.808 -7,046
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Koenig Sheldon L. S - Sale D 2.788 -28,427
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 399.9702 -3,135
2025-09-17 UTHR / United Therapeutics Corporation 4 ROTHBLATT MARTINE A S - Sale D 400.9021 -865
2025-09-17 ESPR / Esperion Therapeutics, Inc. 4 Looker Benjamin S - Sale D 2.804 -6,267
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)